 Connection
Csaba Galambos to Treatment Outcome
This is a "connection" page, showing publications Csaba Galambos has written about Treatment Outcome.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.059 |
|
|
|
-
Constantine E, Bartholomeo AM, Powers I, Lysinger JL, Hauk PJ, Abbott J, de Keyser HH, Gilman NJ, Galambos C, Toland A, Willard N, Weinman J, Mong D, Lin C, Bloom JL. Two unique cases of eosinophilic granulomatosis with polyangiitis in childhood treated with anti-interleukin-5 therapy: infantile-onset and submandibular salivary gland involvement. Pediatr Rheumatol Online J. 2025 Jun 02; 23(1):60.
Score: 0.022
-
Fernandez IZ, Baxter RM, Garcia-Perez JE, Vendrame E, Ranganath T, Kong DS, Lundquist K, Nguyen T, Ogolla S, Black J, Galambos C, Gumbart JC, Dawany N, Kelsen JR, de Zoeten EF, Quinones R, Eissa H, Verneris MR, Sullivan KE, Rochford R, Blish CA, Kedl RM, Dutmer CM, Hsieh EWY. A novel human IL2RB mutation results in T and NK cell-driven immune dysregulation. J Exp Med. 2019 06 03; 216(6):1255-1267.
Score: 0.014
-
Bloom JL, Lin C, Imundo L, Guthery S, Stepenaskie S, Galambos C, Lowichik A, Bohnsack JF. H syndrome: 5 new cases from the United States with novel features and responses to therapy. Pediatr Rheumatol Online J. 2017 Oct 17; 15(1):76.
Score: 0.013
-
Turner Ii RM, Tomaszewski JJ, Fox JA, Galambos C, Cannon GM. Metanephric adenofibroma. Can J Urol. 2013 Apr; 20(2):6737-8.
Score: 0.009
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|